Abstract: A method of identifying AI/ML functionalities/models supported for mobile communication operated in mobile communication systems including a base station and one or more terminals may comprise: identifying, by at least one of the base station or the one or more terminals, information related to the AI/ML functionalities supportable by the one or more terminals; and identifying, by at least one of the base station or the one or more terminals, AI/ML model information supportable by the one or more terminals.

Abstract: A composite insulating material includes two or more blankets, each having a substrate for a blanket and aerogel formed on the inside and a surface of the substrate for the blanket, and a super absorbent polymer layer including super absorbent polymer particles located between the blankets.

Abstract: A method of fabricating a semiconductor device includes determining a concentration of a byproduct in a photoresist composition. A photoresist layer is formed over a substrate using the photoresist composition when the concentration of the byproduct is below a threshold value. A photoresist pattern is formed in the photoresist layer exposing a portion of the substrate, and an operation is performed on the exposed portion of the substrate.

Abstract: The present invention relates to: a recombinant protein in which an interferon-beta mutein, in which an amino acid residue is substituted, and an antibody binding to a specific antigen are fused together; and a pharmaceutical composition for treating cancer, the composition comprising, as active ingredients, a polynucleotide, an expression vector and a recombinant microorganism, and the recombinant protein. In the recombinant protein, the physical properties of interferon-beta are improved through site-specific mutation, and thus the recombinant protein may have improved biological activity and purification efficiency, and the productivity thereof can be increased.

Abstract: A method of a terminal may comprise: receiving a reference signal from a base station; generating a first latent vector based on the reference signal by using an artificial neural network, the first latent vector being common CSI for M resource regions, and M being a positive integer; generating a second latent vector based on the reference signal by using the artificial neural network, the second latent vector being per-resource region CSI for each of the M resource regions; and transmitting structured CSI including the first latent vector and the second latent vectors to the base station.

Abstract: Methods of forming devices comprise forming a dielectric layer on a substrate, the dielectric layer comprising at least one feature defining a gap including sidewalls and a bottom. A self-assembled monolayer (SAM) is formed on the bottom of the gap which resists degradation when exposed to the ambient atmosphere. A barrier layer is selectively deposited on the sidewalls but not on the bottom of the gap. The SAM is removed after selectively depositing the barrier layer on the sidewalls.

Abstract: Methods of forming devices comprise forming a dielectric layer on a substrate, the dielectric layer comprising at least one feature defining a gap including sidewalls and a bottom. A pre-clean process is performed before a self-assembled monolayer (SAM) is formed on the bottom of the gap. A barrier layer is selectively deposited on the sidewalls but not on the bottom of the gap. The SAM is removed after selectively depositing the barrier layer on the sidewalls.

Abstract: Disclosed are a method and an apparatus for improving mobility management performance by reducing unnecessary handovers in a communication system. a method of a terminal may comprise: receiving cell prediction configuration information; generating measurement results by performing measurements on a serving cell and neighbor cell(s) based on signal strength measurement configuration information; and generating a result of predicting a best cell by performing best cell prediction based on the measurement results.

Abstract: The present invention relates to a novel method for isolating and culturing dermal papilla cells. Particularly, in the isolation and culture method of the present invention, by culturing dermal papilla tissue isolated from the scalp under hypoxic conditions, dermal papilla cells separated from the dermal papilla tissue are rapidly attached to a culture plate, thus having the effect of shortening the period of establishing (harvesting) dermal papilla cells, and the isolated and cultured dermal papilla cells have immunocompatibility, and thus can be effectively used for the allogeneic transplantation of dermal papilla cells.

Abstract: A display apparatus includes a substrate with a plurality of pixel areas. The display apparatus includes a light-emitting device formed in a pixel area for emitting light. An encapsulation unit is formed on the light-emitting device. The display apparatus includes a black matrix on the encapsulation unit, where an opening in the black matrix overlaps with the light-emitting device in a first direction. An upper surface of the control insulating layer is formed with a groove that is a recessed portion toward the substrate. An optical lens is disposed above the groove in the control insulating layer.

Abstract: The present application provides a positive current collector plate. The positive current collector plate is located between positive tabs and a positive cover plate; the positive current collector plate includes a plate body and an electrical connection part; the electrical connection part extends and protrudes from the plate body toward the positive cover plate and protrudes; the plate body is in contact with the positive tabs; the electrical connection part is in contact with the positive cover plate. The present application also provides a cylindrical battery.

Abstract: The present invention relates to an RNA in-vitro transcript mRNA for intracellular expression of a gene of interest and a pharmaceutical composition comprising same for vaccines. When injected into animal cells, the in-vitro transcript mRNA including the gene of interest according to the present invention allows the protein of interest to be expressed in the animal cell in large quantities, and, as such, can be used as a gene vaccine against autoimmune diseases, infectious diseases, cancer- or tumor-related diseases, inflammatory diseases, and so on.

Abstract: Provided is a tab plate, including a coating area and an empty foil area located on one side of the coating area. A boundary line is formed at the connection position between the empty foil area and the coating area, the empty foil area is cut to form a plurality of tabs of quadrangular structures, and the four sides of each tab include a first side, a second side and a third side; the third side is located in the empty foil area and is close to the boundary line; and the first side is arranged opposite to the second side, both the first side and the second side intersect with the third side, and an included angle a is formed between the first side and the third side, with the included angle a being an acute angle. Further provided in the present application is a wound battery.

Abstract: The present disclosure in some embodiments provides a method and an apparatus for updating software. The present disclosure provides a method of updating software, including providing a user of a vehicle with one or more vehicle software update options, determining whether an update condition is met based on a vehicle software update option, among the one or more vehicle software update options, that is selected by the user, and updating software of the vehicle based on the update condition being met. The vehicle software update options include at least one of a destination-based update or a driving pattern-based update.

Abstract: The present specification relates to an adamantanecarboxylic acid benzyl amide derivative compound, an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof, and a skin whitening composition comprising the same as an active ingredient. Specifically, the compound, according to the present specification, is a compound having a novel structure having adamantanecarboxylic acid bound to an amine compound, and exhibits a skin whitening effect by inhibiting the production of melanin, and thus may be used in various ways as a pharmaceutical composition, a cosmetic composition or a skin preparation for external use.

Abstract: Disclosed are CSI transmission method and apparatus. A method of a terminal may comprise: receiving, from a base station, information on a measurement period for at least one channel state information-reference signal (CSI-RS) and a reporting period for transmitting at least one CSI; receiving the at least one CSI-RS during the measurement period; generating at least one measured CSI based on the at least one CSI-RS; generating at least one predicted CSI through a CSI prediction model based on the at least one CSI-RS and the at least one CSI; and transmitting the at least one measured CSI and the at least one predicted CSI to the base station.

Abstract: A method of a terminal may comprise: receiving augmentation assistance information from a base station; generating augmented channel data by applying the augmentation assistance information to original channel data; and training an artificial neural network using the augmented channel data.

Abstract: A display device including: a display panel; a first substrate attached to a side of the display panel; and a second substrate attached to a side of the first substrate, wherein the display panel includes a first panel test pad and a second panel test pad, the first substrate includes a 1-1 circuit test lead overlapping and connected to the first panel test pad, a 1-2 circuit test lead overlapping and connected to the second panel test pad, a 2-1 circuit test lead overlapping and connected to the second substrate, a 1-1 test lead line connected to the 1-1 circuit test lead, a 1-2 test lead line connected to the 1-2 circuit test lead, and a first test lead line connected to the 2-1 circuit test lead, and the 1-1 test lead line and the 1-2 test lead line are connected to the first test lead line.

Abstract: A semiconductor device is provided. The semiconductor device includes a substrate containing deuterium at a first concentration, an active pattern disposed on the substrate and extending in a first horizontal direction, a gate electrode disposed on the active pattern and extending in a second horizontal direction different from the first horizontal direction, a gate insulating layer disposed between the active pattern and the gate electrode, the gate insulating layer containing deuterium at a second concentration, a first interlayer insulating layer disposed on the gate electrode, a second interlayer insulating layer disposed on the first interlayer insulating layer, and a wiring pattern disposed inside the second interlayer insulating layer, the wiring pattern containing deuterium at a third concentration lower than the first concentration, wherein each of the first to third concentrations is a concentration of deuterium atoms contained in the same unit volume.

Abstract: A glass plate according to the present disclosure includes: a coated area and an uncoated area; a heating layer that is coated on the coated area and includes a conductive material generating heat by receiving power; and two bus bars that extend along an extension direction, that are electrically connected to the heating layer to supply the power to the heating layer, and that are spaced apart from each other along a reference direction orthogonal to the extension direction. The uncoated area includes a plurality of uncoated lines having a length along the reference direction and formed as a single line bent at least once. The plurality of uncoated lines is disposed to be spaced apart along the extension direction.